CYP2D6 polymorphisms influence tamoxifen treatment outcomes in

Medicina, Free Full-Text

CYP2D6 Genotyping for Personalized Therapy of Tamoxifen in Indonesian Women with ER+ Breast Cancer

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects. - Abstract - Europe PMC

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy

CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients

Impact of duration (months, a), age (year, b), and CYP2D6 genotype (UM

CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients

Explore the distribution of (rs35742686, rs3892097 and rs1065852) genetic polymorphisms of cytochrome P4502D6 gene in the Moroccan population, Egyptian Journal of Medical Human Genetics

Biology, Free Full-Text

JPM, Free Full-Text

Full article: Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment

PDF) Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen